GUARDANT HEALTH, INC. Deferred Revenue Recognized
GUARDANT HEALTH, INC. (GH) reported Deferred Revenue Recognized of $33.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-07-30
- GUARDANT HEALTH, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $7.10M, a 29.70% decline year-over-year.
- GUARDANT HEALTH, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $10.10M, a 42.25% increase year-over-year.
- GUARDANT HEALTH, INC. contract with customer, liability, revenue recognized for the quarter ending 2024-03-31 was $7.10M, a 10.94% increase year-over-year.
- GUARDANT HEALTH, INC. contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was $6.40M, a 82.86% increase year-over-year.
- GUARDANT HEALTH, INC. contract with customer, liability, revenue recognized for fiscal 2024 was $35.30M, a 143.45% increase from fiscal 2023.
- GUARDANT HEALTH, INC. contract with customer, liability, revenue recognized for fiscal 2023 was $14.50M, a 4.32% increase from fiscal 2022.
- GUARDANT HEALTH, INC. contract with customer, liability, revenue recognized for fiscal 2022 was $13.90M, a 82.89% increase from fiscal 2021.
- GUARDANT HEALTH, INC. contract with customer, liability, revenue recognized for fiscal 2021 was $7.60M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $33.40M 10-Q · filed 2026-07-30 | ||||
| 2026-03-31 | $7.10M 10-Q · filed 2026-05-07 | ||||
| 2025-09-30 | $29.10M 10-Q · filed 2025-10-29 | ||||
| 2025-06-30 | $19.90M 10-Q · filed 2026-07-30 | ||||
| 2025-03-31 | $10.10M 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | $35.30M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $12.60M 10-Q · filed 2025-10-29 | ||||
| 2024-06-30 | $9.30M 10-Q · filed 2025-07-30 | ||||
| 2024-03-31 | $7.10M 10-Q · filed 2025-04-30 | ||||
| 2023-12-31 | $14.50M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $12.70M 10-Q · filed 2024-11-06 | ||||
| 2023-06-30 | $11.80M 10-Q · filed 2024-08-07 | ||||
| 2023-03-31 | $6.40M 10-Q · filed 2024-05-09 | ||||
| 2022-12-31 | $13.90M 10-K · filed 2025-02-20 | $7.60M 10-K · filed 2023-02-23 | |||
| 2022-09-30 | $7.70M 10-Q · filed 2023-11-06 | ||||
| 2022-06-30 | $5.30M 10-Q · filed 2023-08-03 | ||||
| 2022-03-31 | $3.50M 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | $7.60M 10-K · filed 2024-02-22 | $8.30M 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $8.00M 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | $6.40M 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | $5.00M 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | $5.00M 10-Q · filed 2022-05-05 | $10.20M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $8.80M 10-Q · filed 2021-11-04 | ||||
| 2020-06-30 | $7.60M 10-Q · filed 2021-08-05 | ||||
| 2020-03-31 | $4.00M 10-Q · filed 2020-05-07 | ||||
| 2019-12-31 | $15.20M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | $14.80M 10-Q · filed 2019-11-07 | ||||
| 2019-06-30 | $13.60M 10-Q · filed 2019-08-07 | ||||
| 2019-03-31 | $7.00M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |